Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dong-A Pharmaceutical Co., Ltd. Issues FY 2013 Revenue Outlook Below Analysts' Estimates


Sunday, 20 Jan 2013 10:32pm EST 

Dong-A Pharmaceutical Co., Ltd. announced that it expects its fiscal year 2013 revenue and operating profit to record KRW 1,026 billion and KRW 117 billion, respectively. According to I/B/E/S, analysts on average are expecting the Company to report revenue of KRW 1,038.52 billion for fiscal year 2013. 

Company Quote

127000.0
500.0 +0.40%
1:23am EDT